Keywords
Curation
Ncbi
Racine
Curation
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Apomorphine (pharmacology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Apomorphine (pharmacokinetics) < Apomorphine (pharmacology) < Apomorphine (therapeutic use)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000033 (1999) O K Hassani [France] ; J. FégerEffects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
000069 (1999) Olga Corti [France] ; Amelia Sánchez-Capelo [France] ; Philippe Colin [France] ; Naïma Hanoun [France] ; Michel Hamon [France] ; Jacques Mallet [France]Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson’s disease
000198 (2001) N. Callizot [France] ; J L Guénet ; C. Baillet ; J M Warter ; P. PoindronThe frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome.
000465 (1992) F. Lisovoski [France] ; C. Haby ; E. Borrelli ; C. Schleef ; M O Revel ; C. Hindelang ; J. ZwillerInduction of D2 dopamine receptor mRNA synthesis in a 6-hydroxydopamine parkinsonian rat model.
000713 (1992) O. Rascol [France] ; U. Sabatini ; F. Chollet ; P. Celsis ; J L Montastruc ; J P Marc-Vergnes ; A. RascolSupplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine.
000985 (1991) U. Sabatini ; O. Rascol ; P. Celsis ; G. Houin ; A. Rascol ; J P Marc-Vergnes ; J L MontastrucSubcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms.
000A90 (2010) B. Greco [France] ; S. Lopez ; H. Van Der Putten ; P J Flor ; M. AmalricMetabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease.
000C37 (2011) Estelle Dellapina [France] ; Angélique Gerdelat-Mas ; Fabienne Ory-Magne ; Laure Pourcel ; Monique Galitzky ; Fabienne Calvas ; Marion Simonetta-Moreau ; Claire Thalamas ; Pierre Payoux ; Christine Brefel-CourbonApomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
001068 (2013) Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo CartaStudy of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
001C68 (1995) D. Muguet [France] ; E. Broussolle ; G. ChazotApomorphine in patients with Parkinson's disease.
001C70 (1995) P. Barnéoud [France] ; S. Parmentier ; M. Mazadier ; J M Miquet ; A. Boireau ; P. Dubédat ; J C BlanchardEffects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat.
001C74 (1994) P. Horellou [France] ; E. Vigne ; M N Castel ; P. Barnéoud ; P. Colin ; M. Perricaudet ; P. Delaère ; J. MalletDirect intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.
001D23 (1993) P. Pollak [France] ; A L Benabid ; P. Limousin ; C L Gervason ; E. Jeanneau-NicolleExternal and implanted pumps for apomorphine infusion in parkinsonism.
001D36 (1993) E. Broussolle [France] ; L. Cinotti ; P. Pollak ; P. Landais ; D. Le Bars ; G. Galy ; F. Lavenne ; Y. Khalfallah ; G. Chazot ; F. MauguièreRelief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease.
001D49 (1993) B. Aranda [France] ; P. CramerEffects of apomorphine and L-dopa on the parkinsonian bladder.
001D72 (1993) C L Gervason [France] ; P R Pollak ; P. Limousin ; J E PerretReproducibility of motor effects induced by successive subcutaneous apomorphine injections in Parkinson's disease.
001E33 (1996) M E Llau [France] ; G. Durrieu ; M A Tran ; J M Senard ; O. Rascol ; J L MontastrucA study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.
001E34 (1996) P. Barnéoud [France] ; M. Mazadier ; J M Miquet ; S. Parmentier ; P. Dubédat ; A. Doble ; A. BoireauNeuroprotective effects of riluzole on a model of Parkinson's disease in the rat.
001E74 (1997) S. Palfi [France] ; D. Riche ; E. Brouillet ; M C Guyot ; V. Mary ; F. Wahl ; M. Peschanski ; J M Stutzmann ; P. HantrayeRiluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Apomorphine (pharmacology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Apomorphine (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Apomorphine (pharmacology)
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024